Tango Therapeutics Inc

TNGX · NASDAQ

Research and Development in Biotechnology

Tango Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops drugs and medicines for the treatment of patients. Tango Therapeutics serves customers in the State of Massachusetts.

ESG Scores

Overall ESG

6.1

Environmental

6.6

Social

4.1

Governance

5.6

Gender Diversity

Female Directors0.2857%

Female Executives0.7272727272727273%

CEO GenderFemale

Market Data

Price$26.39-0.25 (-0.94%)

Market Cap$3.80B

P/E Ratio—

EPS$—

52W High$26.81

52W Low$1.03

Beta1.39